GLOBAL MULTIPLEX ASSAY MARKET 2024-2032

Lifesciences | Diagnostic & Biotechnology

GLOBAL MULTIPLEX ASSAY MARKET 2024-2032

Market by Product and Service, Type, Application, Technology, Industry Vertical, and Regional Outlook | Forecast 2024-2032

Request For Customization

Request Custom Report

Request Custom Report

Enquire before buying

Enquire Before Buying

Multiplex assay is a type of immunoassay that uses magnetic beads to simultaneously measure multiple analytes such as proteins, biomolecules, growth factors, cytokines, chemokines, and others in a single experiment. It is a derivative of an ELISA using beads for binding the capture antibody. This technique allows for the simultaneous detection of multiple analytes in a single well or reaction. 

Multiplex assay provides sensitive and highly specific detection of analytes of interest in biological samples. They utilize reagents and consumables during experiments conducted in R&D labs and for disease diagnosis in clinical diagnostics labs and hospitals. For instance, Luminex offers reagents such as LX200-CAL-K25, LX200-CON-K25, xMAP Sheath Fluid, and others.

According to Triton Market Research’s report, the Global Multiplex Assay Market is likely to grow with a CAGR of 8.56% during the forecast period 2024-2032. The market gained $3905.45 million in 2023 and is expected to reach $8235.49 million by 2032.


MARKET PERFORMANCE – DRIVERS, CHALLENGES, AND OPPORTUNITIES

Factors such as the adoption of personalized medicines and the increasing prevalence of chronic conditions drive the studied market on a growth path. There are several advantages of multiplex assay such as the ability to perform multiplex analysis and gather comprehensive data in a single run, proving highly useful for the comprehensive production of personalized medicines. For instance, the administration of warfarin (used to prevent blood clots) is extremely difficult due to genetic variation in different patients and the presence of different drug metabolism enzymes. Hence, multiplex assays are used for panel-based tests that are expected to detect variations in genes in one assay cycle. Furthermore, as the prevalence of chronic diseases increases, the demand for multiplex assays further increases. These assays provide comprehensive and accurate disease profiles, enabling healthcare providers to deliver personalized treatment plans, thereby improving patient outcomes.

However, issues related to cross-reactivity and assay interference and lack of skilled workforce impede the market’s growth. Cross-reactivity and assay interference are significant challenges that can limit the performance of the assay, prevent scaling up of multiplexing, and even lead to inaccurate or false results. Cross-reactivity (CR) occurs when an antibody reacts with an unintended antigen, leading to false-positive results. This is particularly problematic in multiplex assays, where multiple analytes are measured simultaneously. The complexity of biological matrices can contribute to cross-reactivity, as they often contain related proteins, isoforms, and precursors that can interfere with the assay. These analytes often exist at radically different concentrations. Therefore, the assay must have a wide dynamic range to accurately measure all these analytes. However, many assays, such as the Enzyme-Linked Immunosorbent Assay (ELISA), have a dynamic range limited to a few orders of magnitude. This limitation makes it challenging for ELISA multiplex assay to cover the range of individual analytes.

Nevertheless, technological advancements, rapid growth of companion diagnostics, and growth in drug discovery initiatives create opportunities for the studied market. Companion diagnostics are tests or assays that assist in identifying patients who are most likely to benefit from a specific treatment or medication. These tests play a crucial role in the field of precision medicine, which aims to tailor treatments to individual patients based on their unique characteristics. These characteristics can include genetic makeup, biomarker expression, or other diagnostic criteria. By identifying these factors, healthcare providers can ensure that patients receive the most effective treatments for their specific conditions. Besides, they are particularly useful in drug discovery and development as they can provide a lot of information efficiently. This can help to speed up the drug discovery process and reduce costs.



Report scope can be customized per your requirements - Request Free Sample Report

KEY GEOGRAPHIES COVERED:

•         North America: United States and Canada

•         Europe: United Kingdom, France, Germany, Spain, Italy, the Netherlands, and Rest of Europe

•         Asia-Pacific: China, Japan, India, South Korea, ASEAN Countries, Australia & New Zealand, and Rest of Asia-Pacific

•         Latin America: Brazil, Mexico, and Rest of Latin America

•         Middle East and Africa: United Arab Emirates, Saudi Arabia, Turkey, South Africa, and Rest of Middle East & Africa

SEGMENTATION ANALYSIS – MULTIPLEX ASSAY MARKET:

Market by Product and Service:

o Reagents and Consumables

o Instruments and Accessories

o Software and Services

Market by Type:

o Protein-Based Multiplex Assay

o Nucleic Acid-Based Multiplex Assay

o Other Multiplex Assays

In 2023, Protein-based multiplex assay led the market. These assays are used to identify and quantify proteins, widely used for the diagnosis and detection of various diseases such as cancer, infectious diseases, and others.

Market by Application:

o Research and Development

o Clinical Diagnostics

o Companion Diagnostics

Market by Technology:

o Multiplex Protein Microarray

o Multiplex PCR

o Other Technologies

Market by Industry Vertical:

o Pharmaceutical & Biotechnology Companies

o Research Institutes

o Clinical Laboratories

o Hospitals

COMPETITIVE LANDSCAPE:

The competitive landscape helps dive into data about the key players in the multiplex assay market. The strategic initiatives for each of the companies considered have been covered in detail. 

Contracts and Partnerships (January 2023): Agilent Technologies and Akoya Biosciences

Agilent Technologies and Akoya Biosciences collaborated to create multiplex immunohistochemistry assays for tissue analysis. Through this collaboration, they aimed to combine Agilent’s Dako Omnis autostaining instrument with Akoya’s PhenoImager HT imaging platform to facilitate multiplex chromogenic immunohistochemistry and immunofluorescent assays.

Acquisitions & Mergers (October 2023): Thermo Fisher Scientific Inc and Olink Holding

Thermo Fisher Scientific had an agreement to purchase Olink Holding for around $3.1 billion. This acquisition aims to enhance the buyer’s footprint in the field of proteomics. The completion of the acquisition is anticipated by mid-2024.


KEY BENEFITS OF THE REPORT: 

  • Triton Market Research has a collective experience of 25-30 years in the industry, with its analysts and experts encompassing the most infallible research methodology for its market intelligence and industry analysis. 

  • Our research methodology helps in achieving a broader consensus of the market size, shape, and industry trends within each industry segment. 

  • The strategy adopted in designing the research methodology includes the amalgamation of the information assembled from primary and secondary sources, with the assistance of analytical tools to construct the forecast and predictive models.

  • The scope of the market report comprises the current scenario of the global multiplex assay market, along with the detailed overview of the industry outlook, market dynamics, segmentation analysis, regional outlook, and competitive landscape for the period 2024-2032.


FAQs: 

Q 1) Which is the fastest-growing type in the multiplex assay market?

Nucleic acid-based multiplex assay is the fastest-growing type in the multiplex assay market.

Q 2) Which industry vertical comprises the highest market share in the multiplex assay market?

Pharmaceutical & biotechnology companies comprise the highest market share in the multiplex assay market.

Related Reports

ASIA PACIFIC AESTHETIC LASER MARKET 2019-2027
Lifesciences

ASIA PACIFIC AESTHETIC LASER MARKET 2019-2027

Market By Type, Application, E ..

VIEW REPORT
ASIA PACIFIC BIOCHIPS MARKET 2019-2027
Lifesciences

ASIA PACIFIC BIOCHIPS MARKET 2019-2027

Market By Type, Substrate Mate ..

VIEW REPORT
ASIA PACIFIC BIOPSY DEVICE MARKET 2019-2027
Lifesciences

ASIA PACIFIC BIOPSY DEVICE MARKET 2019-2027

Market By Device Type, Therape ..

VIEW REPORT
ASIA PACIFIC DNA VACCINES MARKET 2019-2027
Lifesciences

ASIA PACIFIC DNA VACCINES MARKET 2019-2027

Market By Type, Application, T ..

VIEW REPORT
ASIA-PACIFIC 3D CELL CULTURE MARKET 2019-2027
Lifesciences

ASIA-PACIFIC 3D CELL CULTURE MARKET 2019-2027

Market By Technology, Applicat ..

VIEW REPORT
ASIA-PACIFIC AIRWAY CLEARANCE SYSTEM MARKET 2019-2028
Lifesciences

ASIA-PACIFIC AIRWAY CLEARANCE SYSTEM MARKET 2019-2028

Market By Application, Type, E ..

VIEW REPORT
ASIA-PACIFIC AMNIOTIC MEMBRANE MARKET 2022-2028
Lifesciences

ASIA-PACIFIC AMNIOTIC MEMBRANE MARKET 2022-2028

Market by Type, Application, E ..

VIEW REPORT

Table of Content

1. GLOBAL MULTIPLEX ASSAY MARKET- SUMMARY

2. INDUSTRY OUTLOOK

2.1. IMPACT ANALYSIS ON THE MULTIPLEX ASSAY MARKET

2.1.1. IMPACT OF COVID-19 ON THE MULTIPLEX ASSAY MARKET

2.2. PORTER’S FIVE FORCES MODEL

2.2.1. THREAT OF NEW ENTRANTS

2.2.2. THREAT OF SUBSTITUTE PRODUCTS

2.2.3. BARGAINING POWER OF BUYERS

2.2.4. BARGAINING POWER OF SUPPLIERS

2.2.5. COMPETITIVE RIVALRY

2.3. KEY BUYING IMPACT ANALYSIS

2.3.1. ANALYTE COVERAGE

2.3.2. SPEED

2.3.3. MULTIPLEXING CAPABILITY

2.3.4. EASE OF USE

2.3.5. AUTOMATION

2.4. MARKET ATTRACTIVENESS INDEX

2.5. KEY MARKET STRATEGIES

2.5.1. CONTRACTS AND PARTNERSHIPS

2.5.2. BUSINESS EXPANSIONS & DIVESTITURES

2.5.3. ACQUISITIONS & MERGERS

2.5.4. PRODUCT LAUNCHES & DEVELOPMENTS

2.6. MARKET DRIVERS

2.6.1. ADOPTION OF PERSONALIZED MEDICINES

2.6.2. HIGH ADOPTION OF MULTIPLEX ASSAYS OVER TRADITIONAL METHODS

2.6.3. INCREASING PREVALENCE OF CHRONIC DISEASES

2.7. MARKET CHALLENGES

2.7.1. ISSUES RELATED TO CROSS-REACTIVITY AND ASSAY INTERFERENCE

2.7.2. CHALLENGE IN ACHIEVING ADEQUATE ASSAY RANGE

2.7.3. DEARTH OF SKILLED PROFESSIONALS

2.8. MARKET OPPORTUNITIES

2.8.1. TECHNOLOGICAL ADVANCEMENTS IN ASSAY PLATFORMS

2.8.2. RAPID GROWTH OF COMPANION DIAGNOSTICS

2.8.3. GROWTH IN DRUG DISCOVERY INITIATIVES

2.9. ANALYST PERSPECTIVE

3. GLOBAL MULTIPLEX ASSAY MARKET - BY PRODUCT AND SERVICE

3.1. REAGENTS AND CONSUMABLES

3.2. INSTRUMENTS AND ACCESSORIES

3.3. SOFTWARE AND SERVICES

4. GLOBAL MULTIPLEX ASSAY MARKET - BY TYPE

4.1. PROTEIN-BASED MULTIPLEX ASSAY

4.2. NUCLEIC ACID-BASED MULTIPLEX ASSAY

4.3. OTHER MULTIPLEX ASSAYS

5. GLOBAL MULTIPLEX ASSAY MARKET - BY APPLICATION

5.1. RESEARCH AND DEVELOPMENT

5.2. CLINICAL DIAGNOSTICS

5.3. COMPANION DIAGNOSTICS

6. GLOBAL MULTIPLEX ASSAY MARKET - BY TECHNOLOGY

6.1. MULTIPLEX PROTEIN MICROARRAY

6.2. MULTIPLEX PCR

6.3. OTHER TECHNOLOGIES

7. GLOBAL MULTIPLEX ASSAY MARKET - BY INDUSTRY VERTICAL

7.1. PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES

7.2. RESEARCH INSTITUTES

7.3. CLINICAL LABORATORIES

7.4. HOSPITALS

8. GLOBAL MULTIPLEX ASSAY MARKET – BY REGIONAL OUTLOOK

8.1. NORTH AMERICA

8.1.1. MARKET BY PRODUCT AND SERVICE

8.1.2. MARKET BY TYPE

8.1.3. MARKET BY APPLICATION

8.1.4. MARKET BY TECHNOLOGY

8.1.5. MARKET BY INDUSTRY VERTICAL

8.1.6. COUNTRY ANALYSIS

8.1.6.1. UNITED STATES

8.1.6.1.1. UNITED STATES MULTIPLEX ASSAY MARKET FORECAST & PROSPECTS

8.1.6.2. CANADA

8.1.6.2.1. CANADA MULTIPLEX ASSAY MARKET FORECAST & PROSPECTS

8.2. EUROPE

8.2.1. MARKET BY PRODUCT AND SERVICE

8.2.2. MARKET BY TYPE

8.2.3. MARKET BY APPLICATION

8.2.4. MARKET BY TECHNOLOGY

8.2.5. MARKET BY INDUSTRY VERTICAL

8.2.6. COUNTRY ANALYSIS

8.2.6.1. GERMANY

8.2.6.1.1. GERMANY MULTIPLEX ASSAY MARKET FORECAST & PROSPECTS

8.2.6.2. UNITED KINGDOM

8.2.6.2.1. UNITED KINGDOM MULTIPLEX ASSAY MARKET FORECAST & PROSPECTS

8.2.6.3. FRANCE

8.2.6.3.1. FRANCE MULTIPLEX ASSAY MARKET FORECAST & PROSPECTS

8.2.6.4. ITALY

8.2.6.4.1. ITALY MARKET FORECAST & PROSPECTS

8.2.6.5. SPAIN

8.2.6.5.1. SPAIN MULTIPLEX ASSAY MARKET FORECAST & PROSPECTS

8.2.6.6. NETHERLANDS

8.2.6.6.1. NETHERLANDS MULTIPLEX ASSAY MARKET FORECAST & PROSPECTS

8.2.6.7. REST OF EUROPE

8.2.6.7.1. REST OF EUROPE MULTIPLEX ASSAY MARKET FORECAST & PROSPECTS

8.3. ASIA-PACIFIC

8.3.1. MARKET BY PRODUCT AND SERVICE

8.3.2. MARKET BY TYPE

8.3.3. MARKET BY APPLICATION

8.3.4. MARKET BY TECHNOLOGY

8.3.5. MARKET BY INDUSTRY VERTICAL

8.3.6. COUNTRY ANALYSIS

8.3.6.1. CHINA

8.3.6.1.1. CHINA MULTIPLEX ASSAYS MARKET FORECAST & PROSPECTS

8.3.6.2. JAPAN

8.3.6.2.1. JAPAN MULTIPLEX ASSAYS MARKET FORECAST & PROSPECTS

8.3.6.3. INDIA

8.3.6.3.1. INDIA MULTIPLEX ASSAYS MARKET FORECAST & PROSPECTS

8.3.6.4. ASEAN COUNTRIES

8.3.6.4.1. ASEAN COUNTRIES MULTIPLEX ASSAYS MARKET FORECAST & PROSPECTS

8.3.6.5. AUSTRALIA & NEW ZEALAND

8.3.6.5.1. AUSTRALIA & NEW ZEALAND MULTIPLEX ASSAYS MARKET FORECAST & PROSPECTS

8.3.6.6. SOUTH KOREA

8.3.6.6.1. SOUTH KOREA MULTIPLEX ASSAYS MARKET FORECAST & PROSPECTS

8.3.6.7. REST OF ASIA-PACIFIC

8.3.6.7.1. REST OF ASIA-PACIFIC MULTIPLEX ASSAYS MARKET FORECAST & PROSPECTS

8.4. LATIN AMERICA

8.4.1. MARKET BY PRODUCT AND SERVICE

8.4.2. MARKET BY TYPE

8.4.3. MARKET BY APPLICATION

8.4.4. MARKET BY TECHNOLOGY

8.4.5. MARKET BY INDUSTRY VERTICAL

8.4.6. COUNTRY ANALYSIS

8.4.6.1. BRAZIL

8.4.6.1.1. BRAZIL MULTIPLEX ASSAYS MARKET FORECAST & PROSPECTS

8.4.6.2. MEXICO

8.4.6.2.1. MEXICO MULTIPLEX ASSAYS MARKET FORECAST & PROSPECTS

8.4.6.3. REST OF LATIN AMERICA

8.4.6.3.1. REST OF LATIN AMERICA MULTIPLEX ASSAYS MARKET FORECAST & PROSPECTS

8.5. MIDDLE EAST AND AFRICA

8.5.1. MARKET BY PRODUCT AND SERVICE

8.5.2. MARKET BY TYPE

8.5.3. MARKET BY APPLICATION

8.5.4. MARKET BY TECHNOLOGY

8.5.5. MARKET BY INDUSTRY VERTICAL

8.5.6. COUNTRY ANALYSIS

8.5.6.1. UNITED ARAB EMIRATES

8.5.6.1.1. UNITED ARAB EMIRATES MULTIPLEX ASSAYS MARKET FORECAST & PROSPECTS

8.5.6.2. SAUDI ARABIA

8.5.6.2.1. SAUDI ARABIA MULTIPLEX ASSAYS MARKET FORECAST & PROSPECTS

8.5.6.3. TURKEY

8.5.6.3.1. TURKEY MULTIPLEX ASSAYS MARKET FORECAST & PROSPECTS

8.5.6.4. SOUTH AFRICA

8.5.6.4.1. SOUTH AFRICA MULTIPLEX ASSAYS MARKET FORECAST & PROSPECTS

8.5.6.5. REST OF MIDDLE EAST & AFRICA

8.5.6.5.1. REST OF MIDDLE EAST & AFRICA MULTIPLEX ASSAYS MARKET FORECAST & PROSPECTS

9. COMPETITIVE LANDSCAPE

9.1. ABCAM LIMITED

9.1.1. OVERVIEW

9.1.2. PRODUCT PORTFOLIO

9.2. AGILENT TECHNOLOGIES INC

9.2.1. OVERVIEW

9.2.2. PRODUCT PORTFOLIO

9.2.3. KEY STRENGTHS

9.2.4. KEY CHALLENGES

9.3. BECTON DICKINSON AND COMPANY (BD)

9.3.1. OVERVIEW

9.3.2. PRODUCT PORTFOLIO

9.3.3. KEY STRENGTHS

9.3.4. KEY CHALLENGES

9.4. BIO-RAD LABORATORIES INC

9.4.1. OVERVIEW

9.4.2. PRODUCT PORTFOLIO

9.4.3. KEY STRENGTHS

9.4.4. KEY CHALLENGES

9.5. BIO-TECHNE CORPORATION

9.5.1. OVERVIEW

9.5.2. PRODUCT PORTFOLIO

9.6. F. HOFFMANN-LA ROCHE LTD

9.6.1. OVERVIEW

9.6.2. PRODUCT PORTFOLIO

9.6.3. KEY STRENGTHS

9.6.4. KEY CHALLENGES

9.7. ILLUMINA INC

9.7.1. OVERVIEW

9.7.2. PRODUCT PORTFOLIO

9.7.3. KEY STRENGTHS

9.7.4. KEY CHALLENGES

9.8. MERCK MILLIPORE

9.8.1. OVERVIEW

9.8.2. PRODUCT PORTFOLIO

9.9. OLINK PROTEOMICS AB

9.9.1. OVERVIEW

9.9.2. PRODUCT PORTFOLIO

9.10. QIAGEN NV

9.10.1. OVERVIEW

9.10.2. PRODUCT PORTFOLIO

9.10.3. KEY STRENGTHS

9.10.4. KEY CHALLENGES

9.11. RANDOX LABORATORIES LTD

9.11.1. OVERVIEW

9.11.2. PRODUCT PORTFOLIO

9.12. SEEGENE INC

9.12.1. OVERVIEW

9.12.2. PRODUCT PORTFOLIO

9.13. SIEMENS HEALTHINEERS AG

9.13.1. OVERVIEW

9.13.2. PRODUCT PORTFOLIO

9.13.3. KEY STRENGTHS

9.13.4. KEY CHALLENGES

9.14. THERMO FISHER SCIENTIFIC INC

9.14.1. OVERVIEW

9.14.2. PRODUCT PORTFOLIO

9.14.3. KEY STRENGTHS

9.14.4. KEY CHALLENGES

10. RESEARCH METHODOLOGY & SCOPE

10.1. RESEARCH SCOPE & DELIVERABLES

10.2. SOURCES OF DATA

10.3. RESEARCH METHODOLOGY

List of Tables

TABLE 1: GLOBAL MULTIPLEX ASSAY MARKET, BY REGIONAL OUTLOOK, HISTORICAL YEARS, 2020-2023 (IN $ MILLION)

TABLE 2: GLOBAL MULTIPLEX ASSAY MARKET, BY REGIONAL OUTLOOK, FORECAST YEARS, 2024-2032 (IN $ MILLION)     

TABLE 3: CONTRACTS AND PARTNERSHIPS

TABLE 4: LIST OF BUSINESS EXPANSIONS & DIVESTITURES     

TABLE 5: ACQUISITIONS & MERGERS

TABLE 6: LIST OF NEW PRODUCT LAUNCHES & DEVELOPMENTS  

TABLE 7: GLOBAL MULTIPLEX ASSAY MARKET, BY PRODUCT AND SERVICE, 2024-2032 (IN $ MILLION)        

TABLE 8: GLOBAL MULTIPLEX ASSAY MARKET, BY TYPE, 2024-2032 (IN $ MILLION)

TABLE 9: GLOBAL MULTIPLEX ASSAY MARKET, BY APPLICATION, 2024-2032 (IN $ MILLION)      

TABLE 10: GLOBAL MULTIPLEX ASSAY MARKET, BY TECHNOLOGY, 2024-2032 (IN $ MILLION)     

TABLE 11: GLOBAL MULTIPLEX ASSAY MARKET, BY INDUSTRY VERTICAL, 2024-2032 (IN $ MILLION)    

TABLE 12: GLOBAL MULTIPLEX ASSAY MARKET, BY REGIONAL OUTLOOK, HISTORICAL YEARS, 2020-2023 (IN $ MILLION)

TABLE 13: GLOBAL MULTIPLEX ASSAY MARKET, BY REGIONAL OUTLOOK, FORECAST YEARS, 2024-2032 (IN $ MILLION)

TABLE 14: NORTH AMERICA MULTIPLEX ASSAY MARKET, BY COUNTRY OUTLOOK, 2024-2032 (IN $ MILLION)         

TABLE 15: NORTH AMERICA MULTIPLEX ASSAY MARKET, BY PRODUCT AND SERVICE, 2024-2032 (IN $ MILLION)   

TABLE 16: NORTH AMERICA MULTIPLEX ASSAY MARKET, BY TYPE, 2024-2032 (IN $ MILLION)    

TABLE 17: NORTH AMERICA MULTIPLEX ASSAY MARKET, BY APPLICATION, 2024-2032 (IN $ MILLION) 

TABLE 18: NORTH AMERICA MULTIPLEX ASSAY MARKET, BY TECHNOLOGY, 2024-2032 (IN $ MILLION)

TABLE 19: NORTH AMERICA MULTIPLEX ASSAY MARKET, BY INDUSTRY VERTICAL, 2024-2032 (IN $ MILLION)         

TABLE 20: EUROPE MULTIPLEX ASSAY MARKET, BY COUNTRY OUTLOOK, 2024-2032 (IN $ MILLION)    

TABLE 21: EUROPE MULTIPLEX ASSAY MARKET, BY PRODUCT AND SERVICE, 2024-2032 (IN $ MILLION)        

TABLE 22: EUROPE MULTIPLEX ASSAY MARKET, BY TYPE, 2024-2032 (IN $ MILLION)

TABLE 23: EUROPE MULTIPLEX ASSAY MARKET, BY APPLICATION, 2024-2032 (IN $ MILLION)      

TABLE 24: EUROPE MULTIPLEX ASSAY MARKET, BY TECHNOLOGY, 2024-2032 (IN $ MILLION)     

TABLE 25: EUROPE MULTIPLEX ASSAY MARKET, BY INDUSTRY VERTICAL, 2024-2032 (IN $ MILLION)    

TABLE 26: ASIA-PACIFIC MULTIPLEX ASSAY MARKET, BY COUNTRY OUTLOOK, 2024-2032 (IN $ MILLION)    

TABLE 27: ASIA-PACIFIC MULTIPLEX ASSAY MARKET, BY PRODUCT AND SERVICE, 2024-2032 (IN $ MILLION)        

TABLE 28: ASIA-PACIFIC MULTIPLEX ASSAY MARKET, BY TYPE, 2024-2032 (IN $ MILLION)

TABLE 29: ASIA-PACIFIC MULTIPLEX ASSAY MARKET, BY APPLICATION, 2024-2032 (IN $ MILLION)      

TABLE 30: ASIA-PACIFIC MULTIPLEX ASSAY MARKET, BY TECHNOLOGY, 2024-2032 (IN $ MILLION)     

TABLE 31: ASIA-PACIFIC MULTIPLEX ASSAY MARKET, BY INDUSTRY VERTICAL, 2024-2032 (IN $ MILLION)    

TABLE 32: LATIN AMERICA MULTIPLEX ASSAY MARKET, BY COUNTRY OUTLOOK, 2024-2032 (IN $ MILLION)    

TABLE 33: LATIN AMERICA MULTIPLEX ASSAY MARKET, BY PRODUCT AND SERVICE, 2024-2032 (IN $ MILLION)        

TABLE 34: LATIN AMERICA MULTIPLEX ASSAY MARKET, BY TYPE, 2024-2032 (IN $ MILLION)

TABLE 35: LATIN AMERICA MULTIPLEX ASSAY MARKET, BY APPLICATION, 2024-2032 (IN $ MILLION)      

TABLE 36: LATIN AMERICA MULTIPLEX ASSAY MARKET, BY TECHNOLOGY, 2024-2032 (IN $ MILLION)     

TABLE 37: LATIN AMERICA MULTIPLEX ASSAY MARKET, BY INDUSTRY VERTICAL, 2024-2032 (IN $ MILLION)    

TABLE 38: MIDDLE EAST AND AFRICA MULTIPLEX ASSAY MARKET, BY COUNTRY OUTLOOK, 2024-2032 (IN $ MILLION)     

TABLE 39: MIDDLE EAST AND AFRICA MULTIPLEX ASSAY MARKET, BY PRODUCT AND SERVICE, 2024-2032 (IN $ MILLION)

TABLE 40: MIDDLE EAST AND AFRICA MULTIPLEX ASSAY MARKET, BY TYPE, 2024-2032 (IN $ MILLION)         

TABLE 41: MIDDLE EAST AND AFRICA MULTIPLEX ASSAY MARKET, BY APPLICATION, 2024-2032 (IN $ MILLION)      

TABLE 42: MIDDLE EAST AND AFRICA MULTIPLEX ASSAY MARKET, BY TECHNOLOGY, 2024-2032 (IN $ MILLION)    

TABLE 43: MIDDLE EAST AND AFRICA MULTIPLEX ASSAY MARKET, BY INDUSTRY VERTICAL, 2024-2032 (IN $ MILLION)  

List of Figures

FIGURE 1: GLOBAL MULTIPLEX ASSAY MARKET, BY PRODUCT AND SERVICE, 2023 & 2032, (IN %)        

FIGURE 2: GLOBAL MULTIPLEX ASSAY MARKET, BY REAGENTS AND CONSUMABLES, 2024-2032 (IN $ MILLION)         

FIGURE 3: GLOBAL MULTIPLEX ASSAY MARKET, BY INSTRUMENTS AND ACCESSORIES, 2024-2032 (IN $ MILLION)     

FIGURE 4: GLOBAL MULTIPLEX ASSAY MARKET, BY SOFTWARE AND SERVICES, 2024-2032 (IN $ MILLION)    

FIGURE 5: GLOBAL MULTIPLEX ASSAY MARKET, BY TYPE, 2023 & 2032 (IN %)

FIGURE 6: GLOBAL MULTIPLEX ASSAY MARKET, BY PROTEIN-BASED MULTIPLEX ASSAY, 2024-2032 (IN $ MILLION)     

FIGURE 7: GLOBAL MULTIPLEX ASSAY MARKET, BY NUCLEIC ACID-BASED MULTIPLEX ASSAY, 2024-2032 (IN $ MILLION)

FIGURE 8: GLOBAL MULTIPLEX ASSAY MARKET, BY OTHER MULTIPLEX ASSAYS, 2024-2032 (IN $ MILLION)   

FIGURE 9: GLOBAL MULTIPLEX ASSAY MARKET, BY APPLICATION, 2023 & 2032, (IN %)     

FIGURE 10: GLOBAL MULTIPLEX ASSAY MARKET, BY RESEARCH AND DEVELOPMENT, 2024-2032 (IN $ MILLION)         

FIGURE 11: GLOBAL MULTIPLEX ASSAY MARKET, BY CLINICAL DIAGNOSTICS, 2024-2032 (IN $ MILLION)         

FIGURE 12: GLOBAL MULTIPLEX ASSAY MARKET, BY COMPANION DIAGNOSTICS, 2024-2032 (IN $ MILLION)    

FIGURE 13: GLOBAL MULTIPLEX ASSAY MARKET, BY TECHNOLOGY, 2023 & 2032 (IN %)     

FIGURE 14: GLOBAL MULTIPLEX ASSAY MARKET, BY MULTIPLEX PROTEIN MICROARRAY, 2024-2032 (IN $ MILLION)     

FIGURE 15: GLOBAL MULTIPLEX ASSAY MARKET, BY MULTIPLEX PCR, 2024-2032 (IN $ MILLION)  

FIGURE 16: GLOBAL MULTIPLEX ASSAY MARKET, BY OTHER TECHNOLOGIES, 2024-2032 (IN $ MILLION)         

FIGURE 17: GLOBAL MULTIPLEX ASSAY MARKET, BY INDUSTRY VERTICAL, 2023 & 2032, (IN %)   

FIGURE 18: GLOBAL MULTIPLEX ASSAY MARKET, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, 2024-2032 (IN $ MILLION)

FIGURE 19: GLOBAL MULTIPLEX ASSAY MARKET, BY RESEARCH INSTITUTES, 2024-2032 (IN $ MILLION)         

FIGURE 20: GLOBAL MULTIPLEX ASSAY MARKET, BY CLINICAL LABORATORIES, 2024-2032 (IN $ MILLION)       

FIGURE 21: GLOBAL MULTIPLEX ASSAY MARKET, BY HOSPITALS, 2024-2032 (IN $ MILLION)

FIGURE 22: GLOBAL MULTIPLEX ASSAY MARKET, BY REGIONAL OUTLOOK, 2023 & 2032 (IN %)    

FIGURE 23: NORTH AMERICA MULTIPLEX ASSAY MARKET, BY COUNTRY OUTLOOK, 2023 & 2032 (IN %)         

FIGURE 24: UNITED STATES MULTIPLEX ASSAY MARKET, 2024-2032 (IN $ MILLION)

FIGURE 25: CANADA MULTIPLEX ASSAY MARKET 2024-2032 (IN $ MILLION)        

FIGURE 26: EUROPE MULTIPLEX ASSAY MARKET, BY COUNTRY OUTLOOK, 2023 & 2032 (IN %)     

FIGURE 27: GERMANY MULTIPLEX ASSAY MARKET 2024-2032 (IN $ MILLION)        

FIGURE 28: UNITED KINGDOM MULTIPLEX ASSAY MARKET 2024-2032 (IN $ MILLION)

FIGURE 29: FRANCE MULTIPLEX ASSAY MARKET 2024-2032 (IN $ MILLION)        

FIGURE 30: ITALY MULTIPLEX ASSAY MARKET 2024-2032 (IN $ MILLION)       

FIGURE 31: SPAIN MULTIPLEX ASSAY MARKET 2024-2032 (IN $ MILLION)       

FIGURE 32: NETHERLANDS MULTIPLEX ASSAY MARKET 2024-2032 (IN $ MILLION)

FIGURE 33: REST OF EUROPE MULTIPLEX ASSAY MARKET 2024-2032 (IN $ MILLION)

FIGURE 34: ASIA-PACIFIC MULTIPLEX ASSAY MARKET, BY COUNTRY OUTLOOK, 2023 & 2032 (IN %)     

FIGURE 35: CHINA MULTIPLEX ASSAY MARKET 2024-2032 (IN $ MILLION)       

FIGURE 36: JAPAN MULTIPLEX ASSAY MARKET 2024-2032 (IN $ MILLION)       

FIGURE 37: INDIA MULTIPLEX ASSAY MARKET 2024-2032 (IN $ MILLION)       

FIGURE 38: ASEAN COUNTRIES MULTIPLEX ASSAY MARKET 2024-2032 (IN $ MILLION)     

FIGURE 39: AUSTRALIA & NEW ZEALAND MULTIPLEX ASSAY MARKET 2024-2032 (IN $ MILLION)   

FIGURE 40: SOUTH KOREA MULTIPLEX ASSAY MARKET 2024-2032 (IN $ MILLION)

FIGURE 41: REST OF ASIA-PACIFIC MULTIPLEX ASSAY MARKET 2024-2032 (IN $ MILLION)     

FIGURE 42: LATIN AMERICA MULTIPLEX ASSAY MARKET, BY COUNTRY OUTLOOK, 2023 & 2032 (IN %)         

FIGURE 43: BRAZIL MULTIPLEX ASSAYS MARKET 2024-2032 (IN $ MILLION)        

FIGURE 44: MEXICO MULTIPLEX ASSAYS MARKET 2024-2032 (IN $ MILLION)        

FIGURE 45: REST OF LATIN AMERICA MULTIPLEX ASSAYS MARKET 2024-2032 (IN $ MILLION)     

FIGURE 46: MIDDLE EAST AND AFRICA MULTIPLEX ASSAY MARKET, BY COUNTRY OUTLOOK, 2023 & 2032 (IN %)    

FIGURE 47: UNITED ARAB EMIRATES MULTIPLEX ASSAYS MARKET 2024-2032 (IN $ MILLION)     

FIGURE 48: SAUDI ARABIA MULTIPLEX ASSAYS MARKET 2024-2032 (IN $ MILLION)

FIGURE 49: TURKEY MULTIPLEX ASSAYS MARKET 2024-2032 (IN $ MILLION)        

FIGURE 50: SOUTH AFRICA MULTIPLEX ASSAYS MARKET 2024-2032 (IN $ MILLION)

FIGURE 51: REST OF MIDDLE EAST & AFRICA MULTIPLEX ASSAYS MARKET 2024-2032 (IN $ MILLION)  

Purchase Options

  • Licence Type
  • Price
  • User/Sharing
  • Printing
  • Delivery Formats
  • Free customization (Pre-sale)
  • Analyst hour support (Post Sale)
  • Customized notification for newly published report
  • Free report on update (within 180 days)

Single User PDF

$2,750.00

  • User/Sharing
  • Restricted to one authorized user
  • Printing
  • Not printable
  • Delivery Formats
  • Pdf
  • Free customization (Pre-sale)
  • 10% Free customization
  • Analyst hour support (Post Sale)
  • 3 hours
  • Customized notification (newly published)
  • Free report on update (within 180 days)

Enterprise Online/PDF

$4,000.00

  • User/Sharing
  • Unlimited
  • Printing
  • Unlimited
  • Delivery Formats
  • Pdf and market estimation excel
  • Free customization (Pre-sale)
  • 20% Free customization
  • Analyst hour support (Post Sale)
  • 8 hour
  • Customized notification (newly published)
  • Free report on update (within 180 days)

Request free Sample

Request Custom Report

Request Custom Report

Enquire before buying

Enquire Before Buying